Key Highlights

  • SCWorx (NASDAQ:WORX) traded at USD 1.74, up 21.71% intraday on November 4, 2026, with 3.28 million shares changing hands according to published market data.
  • No company announcement dated November 2 to November 4, 2026 was identified, so the move appears trading driven rather than tied to a new filing or release.
  • The Nasdaq Hearings Panel approved continued listing on October 5, 2026, with a one-year monitoring period ending October 2, 2027, and trading resumed on October 7.
  • The company reported unaudited first-half 2026 Revenue of about USD 1.45 million and a net loss of about USD 295,000, so the Business remains very small.

What Moved SCWorx During Trading (up USD 0.31, 21.71%)

SCWorx (NASDAQ:WORX) was quoted at USD 1.74 during regular trading hours on November 4, 2026, up 21.71%. The implied prior close is USD 1.43 (calculated), so the gain equals about USD 0.31 per share. Published market data showed 3.28 million shares traded and a market Capitalization of roughly USD 2.41 million, a figure that could not be reconciled with company filings and should be treated with caution. After searching company releases, exchange notices and filings, no announcement dated November 2 to November 4, 2026 was identified. The move is therefore best described as trading driven, which means the reason for the buying is not disclosed and could be short-term positioning rather than a change in the business.

Recent Context: Nasdaq Listing and Financing

The most relevant recent events concern the listing. On June 23, 2026 the Nasdaq Hearings Panel allowed continued listing subject to conditions, including a Reverse Stock Split and a bid-price recovery deadline. On July 29, 2026 the panel issued a partial compliance letter, noting the company still had to hold a USD 1.00 minimum closing bid for 20 consecutive trading days. On October 5, 2026 the panel approved continued listing on the Nasdaq Capital Market with monitoring through October 2, 2027, and the company announced that trading would resume at the open on October 7. The company also closed an Equity Financing on September 17, 2026, selling 350,000 units at USD 2.68 for about USD 938,000 gross. Today's quote is below that unit price.

Business Update and Risks for Small Traders

SCWorx provides data management services for healthcare Supply chains. On October 19, 2026 it announced an agreement with an independent, community-owned health system in the Southwest, and on August 6, 2026 a two-year agreement with a Massachusetts integrated delivery network. Unaudited first-half 2026 revenue was about USD 1.45 million, with a net loss of about USD 295,000. The stock is a micro cap, so a small number of trades can move the price, bid-ask spreads can be wide and quoted moves can reverse quickly. A price near USD 1.74 also sits not far above the USD 1.00 minimum bid, so a decline could revive listing questions. Equity financings dilute existing holders because new shares spread the same Earnings over more shares.

Where Things Stand

SCWorx (NASDAQ:WORX) is up 21.71% on November 4, 2026 without a company announcement from November 2 to November 4 that we could identify, so the move looks trading driven. The recent backdrop is a Nasdaq decision that allows continued listing under monitoring, a small equity raise and a new customer agreement, yet the company's revenue base is tiny. Quoted moves in micro caps can reverse, and nothing here suggests the gain will continue. This article is informational and is not Investment advice.